Join
Live feed
·
PRReleasevia Quantisnow
Scholar Rock Holding Corporation logo

Scholar Rock Announces FDA Review of Apitegromab Biologics License Application (BLA) for Spinal Muscular Atrophy (SMA) to Progress with Second Fill-Finish Facility; Approval Decision Anticipated by September 30, 2026 Action Date

ByQuantisnow·Wall Street's wire, on your screen.
SRRK· Scholar Rock Holding Corporation
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SRRK (Scholar Rock Holding Corporation) and more on Quantisnow.